An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin

This case suggests that initiation of HCV therapy immediately after liver transplantation with well‐tolerated, all‐oral regimens may achieve a virologic cure in HCV‐positive recipients, thus preventing post‐transplant HCV recurrence and associated disease progression. This strategy may broaden utili...

Descripción completa

Detalles Bibliográficos
Autores principales: Poordad, Fred, Lawitz, Eric, Gutierrez, Julio A., Guerrero, Juan, Speeg, Kermit, Swenson, Eugene S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378822/
https://www.ncbi.nlm.nih.gov/pubmed/28396749
http://dx.doi.org/10.1002/ccr3.841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378822/
https://www.ncbi.nlm.nih.gov/pubmed/28396749
http://dx.doi.org/10.1002/ccr3.841

Ejemplares similares